当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3847427
已选条件
-
T2547DroxidopaDOPS;SM5688;L-DOPS;屈昔多巴;屈西多巴
Droxidopa is an orally available prodrug of norepinephrine that is used in the treatment of symptomatic orthostatic hypotension due to neurogenic causes of autonomic failure.
价 格:¥电议型 号:T2547产 地:中国大陆
-
T2547DroxidopaDroxidopa,DOPS,SM5688
Droxidopa is an orally available prodrug of norepinephrine that is used in the treatment of symptomatic orthostatic hypotension due to neurogenic causes of autonomic failure.
价 格:¥电议型 号:T2547产 地:美洲
-
T60369Droxidopa hydrochloride;化合物 Droxidopa hydrochlorideDroxidopa hydrochloride
Droxidopa (L-DOPS) hydrochloride is a potent, orally active precursor to norepinephrine that elevates standing blood pressure, mitigates orthostatic hypotension symptoms, and enhances standing capability. It holds promise for research in neurogenic orthostatic hypotension (nOH) and alternative attention deficit hyperactivity disorder (ADHD) treatments [1] [2] [3] [4].
价 格:¥电议型 号:T60369产 地:中国大陆
-
T2547Droxidopa;屈昔多巴SM5688|||DOPS|||L-DOPS;屈昔多巴|||屈西多巴|||SM5688|||DOPS|||L-DOPS
Droxidopa (L-DOPS) is an orally available prodrug of norepinephrine that is used in the treatment of symptomatic orthostatic hypotension due to neurogenic causes of autonomic failure.
价 格:¥电议型 号:T2547产 地:中国大陆